Acne drug offers hope for stroke victims

My Account
Logout

Create an Evening Standard Account

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Welcome! Sign in here

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Forgot your password ?

Registration

* indicates fields that are mandatory

Email *

Password *

Confirm Password *

First name *

Surname *

Postcode *

Country *

Mobile phone number

Username *

Gender *

Year of birth *

When you sign up...

You will have access to all our online competitions, discounted offers and can post comments on our site.

You will also receive The Weekender newsletter sent every Thursday - it’s full of fantastic offers and ideas for the weekend. You can update your email preferences in your account page when you log in.

Other newsletters and emails

Homes & Property Newsletter - Yes I want to receive the weekly email with all the latest news on property in the capital

Occasionally we would also like to send you relevant emails detailing specific offers either from ourselves or carefully selected partners. If you would prefer not to receive these then please tick the appropriate boxes below. We will never pass on your details.

I do not want to receive additional offers and information from the Evening Standard

I do not want to receive additional offers and information sent by Evening Standard on behalf of carefully selected partners

Terms and Conditions

* I have read, understood and agree to be bound by the terms and conditions of Evening Standard

Registration

Mail Sent for Registration Confirmation.

A confirmation email has been sent. Please activate your account by clicking on the activation link sent in your mail box.

New research shows that when the drug minocycline was given within 24 hours of a stroke, it reduced brain damage and physical and mental impairment.

Results from the trial at Tel Aviv University, Israel, based on 150 patients, show that those given the drug six to 24 hours after suffering the most common type of stroke, caused by a blood clot, did much better than those given a dummy pill.

The conditions of the patients were rated the same when they arrived at hospital, but as soon as seven days later, those who had been taking the drug for five days were showing superior overall improvements.

Just how the antibiotic works is not clear, but one theory is that it has a beneficial effect on inflammation and that it may slow or prevent cell death.

An estimated 150,000 people have a stroke in the UK each year, and strokes are responsible for more than 67,000 deaths, making it the third most common cause of death after heart disease and cancer.

Stroke has a greater disability impact than any other chronic disease, with more than 300,000 stroke victims living with moderate to severe disabilities.

Stroke patients occupy 20 per cent of all acute hospital beds and 25 per cent of long-term beds.

Traditional treatments include surgery to remove arterial plaques, and clot-dissolving drugs, which restore blood flow to the brain.